Paul A Brooke
CIK 1175940 · Chairman and CEO · last filed 2020-04-02
Paul A Brooke is a Chairman and CEO who has filed 80 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing shows the insider was granted $23.9K of INCY on Apr 2, 2020. Across all open-market trades the lifetime net is −$4.4M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $32.4M across reported positions. 50 SEC filings were submitted jointly with INCYTE CORP.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
INCY price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2591 WEXFORD BAYNE RD
SEWICKLEY, PA 15143
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INCY | Director | 261,911 | $116.11 | $30.41M | -$2.19M | 42 | 2020-04-02 |
| VIROPHARMA INC (VPHM) Delisted | Director | 129,000 | — | — | -$1.43M | 11 | 2014-01-08 |
| WebMD Health Corp. (WBMD) Delisted | Director | 162,536 | — | — | $0 | 3 | 2010-01-04 |
| HLTH | Director | 70,000 | $27.74 | $1.94M | -$806.8K | 5 | 2009-01-05 |
| Alsius Corp (ALUSW) Delisted | Director | 1,262,650 | — | — | $0 | 2 | 2008-01-15 |
Recent Filings
80 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-02 | INCY | Grant (A) | +327 | $23.9K | EDGAR |
| 2020-02-25 | INCY | Exer (M) | +20,000 | $266.8K | EDGAR |
| 2020-01-03 | INCY | Grant (A) | +264 | $23.1K | EDGAR |
| 2019-10-02 | INCY | Grant (A) | +304 | $22.6K | EDGAR |
| 2019-07-02 | INCY | Grant (A) | +291 | $24.7K | EDGAR |
| 2019-04-29 | INCY | Grant (A) | +1,520 | $0 | EDGAR |
| 2019-04-02 | INCY | Grant (A) | +276 | $23.7K | EDGAR |
| 2019-01-03 | INCY | Grant (A) | +373 | $23.7K | EDGAR |
| 2018-10-02 | INCY | Grant (A) | +343 | $23.7K | EDGAR |
| 2018-07-03 | INCY | Mixed | +354 | $23.7K | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.